Zobrazeno 1 - 10 of 22 pro vyhledávání: '"Ann Vu"'
1
Akademický článek
Approach to the diagnosis and treatment of non-tuberculous mycobacterial disease
Autor: Kelly M. Pennington, Ann Vu, Douglas Challener, Christina G. Rivera, F.N.U. Shweta, John D. Zeuli, Zelalem Temesgen
Publikováno v: Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, Vol 24, Iss , Pp 100244- (2021)
Non-tuberculous mycobacteria (NTM) is a collective name given to a group of more than 190 species of Mycobacterium. The clinical presentation for most NTM infections is non-specific, often resulting in delayed diagnosis. Further complicating matters
Externí odkaz: https://doaj.org/article/96040b7d045c4941a3260af1cacb7738
Zobrazit plný text záznamu
2
Approach to the diagnosis and treatment of non-tuberculous mycobacterial disease
Autor: Ann Vu, John D. Zeuli, Christina G. Rivera, Zelalem Temesgen, Douglas W. Challener, F. N.U. Shweta, Kelly Pennington
Publikováno v: Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, Vol 24, Iss, Pp 100244-(2021)
Non-tuberculous mycobacteria (NTM) is a collective name given to a group of more than 190 species of Mycobacterium. The clinical presentation for most NTM infections is non-specific, often resulting in delayed diagnosis. Further complicating matters
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dec4358003828e48105943e07bbf93ae
http://europepmc.org/articles/PMC8135042
Zobrazit plný text záznamu
7
Clarifying the diagnosis of post-inflammatory pulmonary fibrosis: a population-based study
Autor: Amit Vasireddy, Misbah Baqir, Jay H. Ryu, Teng Moua, Ann Vu
Publikováno v: The European respiratory journal. 54(1)
Patients with post-inflammatory pulmonary fibrosis were found to be a heterogeneous population, and the vast majority did not have IPF or any form of interstitial lung diseasehttp://bit.ly/2wcqepC
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e4a1ef571acfa82987c287d5b1fb24c
https://pubmed.ncbi.nlm.nih.gov/30956211
Zobrazit plný text záznamu
8
Exacerbation of Previously Undiagnosed Bird Fancier's Lung by Pembrolizumab Therapy
Autor: Jay H. Ryu, Robert Vassallo, Ann Vu
Publikováno v: Chest. 155(4)
Immune checkpoint inhibitors have revolutionized cancer therapy. As the use of checkpoint inhibitors becomes widespread, the early recognition and treatment of their unique spectrum of adverse effects, called immune-related adverse events, become cri
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4afe4858933112bbead2bb1bda2886d
https://pubmed.ncbi.nlm.nih.gov/30955583
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje